ArticleBMC bioinformatics2023
GACNNMDA: a computational model for predicting potential human microbe-drug associations based on graph attention network and CNN-based classifier.
Article in BMC bioinformatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 30 citations in OpenAlex.
- BCheM: a framework integrating molecular attributes and behavioral representations for precise prediction of drug resistance across multiple disease contexts.Frontiers in bioinformatics · 2026Article
- A microbe-drug association prediction model based on graph attention networks and rotation forest.Frontiers in bioinformatics · 2026Article
- Dynamic category-sensitive hypergraph inferring and homo-heterogeneous neighbor feature learning for drug-related microbe prediction.Bioinformatics (Oxford, England) · 2024Article
- GCGACNN: A Graph Neural Network and Random Forest for Predicting Microbe-Drug Associations.Biomolecules · 2024Article
- A novel microbe-drug association prediction model based on graph attention networks and bilayer random forest.BMC bioinformatics · 2024Article
- Multi-scale topology and position feature learning and relationship-aware graph reasoning for prediction of drug-related microbes.Bioinformatics (Oxford, England) · 2024Article
- NMGMDA: a computational model for predicting potential microbe-drug associations based on minimize matrix nuclear norm and graph attention network.Scientific reports · 2024Article
- Prediction of microbe-drug associations based on a modified graph attention variational autoencoder and random forest.Frontiers in microbiology · 2024Article
- LCASPMDA: a computational model for predicting potential microbe-drug associations based on learnable graph convolutional attention networks and self-paced iterative sampling ensemble.Frontiers in microbiology · 2024Article
- BANNMDA: a computational model for predicting potential microbe-drug associations based on bilinear attention networks and nuclear norm minimization.Frontiers in microbiology · 2024Article
- OGNNMDA: a computational model for microbe-drug association prediction based on ordered message-passing graph neural networks.Frontiers in genetics · 2024Article
- A novel microbe-drug association prediction model based on stacked autoencoder with multi-head attention mechanism.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As new drug targets, human microbes are proven to be closely related to human health. Effective computational methods for inferring potential microbe-drug associations can provide a useful complement to conventional experimental methods and will facilitate drug research and development. However, it is still a challenging work to predict potential interactions for new microbes or new drugs, since the number of known microbe-drug associations is very limited at present. In this manuscript, we first constructed two heterogeneous microbe-drug networks based on multiple measures of similarity of microbes and drugs, and known microbe-drug associations or known microbe-disease-drug associations, respectively. And then, we established two feature matrices for microbes and drugs through concatenating various attributes of microbes and drugs. Thereafter, after taking these two feature matrices and two heterogeneous microbe-drug networks as inputs of a two-layer graph attention network, we obtained low dimensional feature representations for microbes and drugs separately. Finally, through integrating low dimensional feature representations with two feature matrices to form the inputs of a convolutional neural network respectively, a novel computational model named GACNNMDA was designed to predict possible scores of microbe-drug pairs. Experimental results show that the predictive performance of GACNNMDA is superior to existing advanced methods. Furthermore, case studies on well-known microbes and drugs demonstrate the effectiveness of GACNNMDA as well. Source codes and supplementary materials are available at: https://github.com/tyqGitHub/TYQ/tree/master/GACNNMDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.